|
Volumn 362, Issue 9394, 2003, Pages 1499-
|
Antiretroviral therapy: Challenges and options in South Africa [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BIOAVAILABILITY;
GOVERNMENT;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MEDICAL DECISION MAKING;
PRIORITY JOURNAL;
PUBLIC HEALTH;
REDUCTION;
RISK FACTOR;
SEXUALLY TRANSMITTED DISEASE;
SOUTH AFRICA;
STANDARD;
SUPERINFECTION;
|
EID: 0242266574
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(03)14700-9 Document Type: Letter |
Times cited : (4)
|
References (2)
|